Armistice Capital, LLC Htg Molecular Diagnostics, Inc Transaction History

Armistice Capital, LLC

  • $6.02 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.46 - $1.45 $383,664 - $1.21 Million
-834,054 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$1.39 - $5.51 $1.16 Million - $4.6 Million
834,054 New
834,054 $1.16 Million

Others Institutions Holding HTGM

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About HTG MOLECULAR DIAGNOSTICS, INC

HTGM Quotes by TradingView
  • Ticker HTGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 11,048,100
  • Market Cap $3.76M
  • Description
  • HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-o...
More about HTGM
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email